About: Respiratory Support in Severely or Critically Ill ICU Patients With COVID-19 in Wuhan, China

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Respiratory Support in Severely or Critically Ill ICU Patients With COVID-19 in Wuhan, China Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Respiratory Support in Severely or Critically Ill ICU Patients With COVID-19 in Wuhan, China
Creator	Wang, Jing Xu, Shen Hu, Hong-Tao Rao, Xin
Source	Medline; PMC
abstract	This case series aimed to describe the clinical characteristics of severely or critically ill patients with COVID-19 and compare the clinical characteristics of patients who received invasive respiratory support with those of patients who received noninvasive respiratory support. We included all confirmed severe or critical illness cases of COVID-19 admitted to the Intensive Care Unit (ICU) of Zhongnan Hospital of Wuhan University, a COVID-19-designated hospital, from January 8 to March 12, 2020. Cases were analyzed for epidemiological, demographic, clinical, APACHE II, SOFA, radiological features and laboratory data. Outcomes of all patients were followed up as of March 12, 2020. This newly emerging virus had caused 55 confirmed severe or critical illness cases in ICU of a COVID-19-designated hospital. Most of the infected patients were men; more than half had underlying diseases, including hypertension, coronary artery disease and diabetes. The median age was 63 years old. Common symptoms at onset of illness were fever, fatigue and dry cough. Five (9.1%) hospitalized patients were presumed to have been infected in the hospital, and 4 (7.3%) health care workers were infected in their work. Of the 55 confirmed severe or critical illness cases, 10 (18.2%) patients died during the follow-up period as of March 12 with the median follow-up period of 28 days (interquartile range 16–35). Nine patients received VV-ECMO for severe respiratory failure and 4 (44.4%) patients died. Moreover, 28 patients received invasive respiratory support and 14 (50.0%) patients died. In this single-center study, 55 severely or critically ill ICU patients were confirmed to have COVID-19 in Wuhan and the overall mortality was 29.1%. Totally 28 (50.9%) of severely or critically ill ICU patients received invasive respiratory support and 14 (50.0%) died during the follow-up period.
has issue date	2020-08-07(xsd:dateTime)
bibo:doi	10.1007/s11596-020-2227-8
bibo:pmid	32767265
has license	no-cc
sha1sum (hex)	b463ca6295c358f88cbff914cf86c0d7be71c23b
schema:url	https://doi.org/10.1007/s11596-020-2227-8
resource representing a document's title	Respiratory Support in Severely or Critically Ill ICU Patients With COVID-19 in Wuhan, China
has PubMed Central identifier	PMC7412770
has PubMed identifier	32767265
schema:publication	Curr Med Sci
resource representing a document's body	covid:b463ca6295c358f88cbff914cf86c0d7be71c23b#body_text
is schema:about of	named entity 'epidemiological' named entity 'patients' named entity 'ICU' named entity 'FOLLOWED' named entity 'UNDERLYING' named entity 'WUHAN' named entity 'MORE THAN' named entity 'CASES' named entity 'WORKERS' named entity 'DIED' named entity 'MEDIAN' named entity '2818' named entity 'SOFA' named entity 'describe' named entity 'March 12' named entity 'critical illness' named entity 'received' named entity 'critically ill' named entity 'data' named entity 'invasive' named entity 'invasive' named entity 'hypertension' named entity 'median age' named entity 'Wuhan' named entity 'epidemiological' named entity 'March 12' named entity 'Wuhan University' named entity 'underlying diseases' named entity 'clinical characteristics' named entity 'critically ill' named entity 'COVID' named entity 'fatigue' named entity 'Respiratory Support' named entity 'invasive' named entity 'immune function' named entity 'lymphocytes' named entity 'meta-analysis' named entity 'lung' named entity 'ECMO' named entity 'clinical characteristics' named entity 'lymphocytes' named entity 'COVID' named entity 'Wuhan' named entity 'respiratory support' named entity 'ECMO' named entity 'IFNγ' named entity 'lung' named entity 'arterial partial pressure of oxygen' named entity 'ground glass opacities' named entity 'inhalation' named entity 'Th1' named entity 'ECMO' named entity 'respiratory support' named entity 'Wuhan' named entity 'extracorporeal membrane oxygenation' named entity 'COVID' named entity 'ECMO' named entity 'clinical characteristics' named entity 'Fisher's exact test' named entity '8 days' named entity 'organ failure' named entity 'infection' named entity 'invasive mechanical ventilation' named entity 'Wuhan' named entity 'SARS-CoV-2' named entity 'acute respiratory failure' named entity 'lung function' named entity 'IRS' named entity 'prognosis' named entity 'China' named entity '3, 4' named entity 'IRS' named entity 'acute respiratory failure' named entity 'COVID-19' named entity 'respiratory support' named entity 'partial pressure' named entity 'kaletra' named entity 'China'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software